Cargando…

Interleukin-6 and statin therapy: potential role in the management of COPD

Detalles Bibliográficos
Autores principales:	Young, Robert P, Hopkins, Raewyn J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718655/ https://www.ncbi.nlm.nih.gov/pubmed/23865731 http://dx.doi.org/10.1186/1465-9921-14-74

Ejemplares similares

Management of statin myopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Endometrial Cancer and The Role of Statins
por: Humayun, Ammar, et al.
Publicado: (2015)

Interleukin-6 as a potential biomarker of COVID-19 progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
por: Lee, Jun-beom, et al.
Publicado: (2017)

Right atrial myxoma: a potential accelerator of pulmonary hypertension in the course of systemic sclerosis. The role of interleukin-6
por: Peregud-Pogorzelska, Małgorzata, et al.
Publicado: (2019)

Statin Therapy in COVID-19: Inhibition of NETosis
por: Kow, Chia Siang, et al.
Publicado: (2022)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?
por: Young, Robert P, et al.
Publicado: (2011)

Lack of accurate evidence on non-statin medication in patients receiving high-intensity statin therapy: Re-evaluation of recommendations is needed
por: Demirci, Deniz, et al.
Publicado: (2018)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19
por: Vityala, Yethindra, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
por: Cafarotti, Stefano
Publicado: (2020)

Increased risk of diabetes with statin use: Reconsidering the use of high potency statins
por: Niazi, Asfandyar Khan
Publicado: (2014)

FAM13A locus in COPD is independently associated with lung cancer – evidence of a molecular genetic link between COPD and lung cancer
por: Young, Robert P, et al.
Publicado: (2010)

Statins are detrimental to human placental development and function; use of statins during early pregnancy is inadvisable
por: Forbes, Karen, et al.
Publicado: (2008)

The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score
por: Akşit, Ercan, et al.
Publicado: (2023)

Interleukin-6 and severity of COVID-19 patients in Hefei, China
por: Zhao, Z., et al.
Publicado: (2020)

Management Strategies of COPD during the COVID-19 Pandemic
por: Pandey, Anuj Kumar, et al.
Publicado: (2023)

Genetic evidence linking lung cancer and COPD: a new perspective
por: Young, Robert P, et al.
Publicado: (2011)

Chronic urticaria and use of statins
por: Khan, Sujoy
Publicado: (2012)

Statins for Patients with Cardiogenic Shock
por: Champion, Sébastien
Publicado: (2014)

Do Not Treat Children with Statins
por: Diamond, David M., et al.
Publicado: (2019)

Increased serum interleukin-6 levels in patients with hidradenitis suppurativa
por: Xu, Haoxiang, et al.
Publicado: (2017)

Aortic Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage: Role of Antihypertensive Drugs and Statins
por: Varol, Ercan, et al.
Publicado: (2015)

Arterial stiffness evaluation in patients with irritable bowel syndrome: Role of antihypertensive drugs and statins
por: Varol, Ercan
Publicado: (2015)

A novel role for interleukin 32 in cholestasis
por: Zhang, Xiaoxun, et al.
Publicado: (2021)

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Creatine kinase levels in asthma patients receiving interleukin-5 therapy
por: Kavanagh, Grace A., et al.
Publicado: (2022)

Do statins prevent or promote cancer?
por: Goldstein, Mark R., et al.
Publicado: (2008)

Higher dose statins after stroke
Publicado: (2021)

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients
por: O'Byrne, K J, et al.
Publicado: (2000)

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients – reply
por: Salgado, R, et al.
Publicado: (2000)

Linear scleroderma “en coup de sabre” with extensive brain involvement—Clinicopathologic correlations and response to anti-Interleukin-6 therapy
por: Magro, Cynthia M., et al.
Publicado: (2019)

Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”
por: Cattaneo, Dario, et al.
Publicado: (2021)

Interleukin-17: A potential therapeutic target in COVID-19
por: Mendoza, Vicky M. Montaño
Publicado: (2020)

Medicinal Plants and New Concerns in Statin Consumption
por: NASRI, Hamid, et al.
Publicado: (2013)

Near-Fatal Statin-Associated Autoimmune Myositis
por: Vithayathil, Mathew, et al.
Publicado: (2018)

Creatine, guanidinoacetate and homoarginine in statin-induced myopathy
por: Neu, Axel, et al.
Publicado: (2020)

Statin doses after acute coronary syndrome
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7vfumsjghllv4ckkbm1kb24uf